Sumant Chugh is a Nephrology physician. OpenAlex indexes 66 publications with 2,917 citations (h-index 24).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
619 19th Street South
Birmingham, AL 35233
Telephone
205-934-6600Registry record last updated 7 Jul 2011.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.3%Loop diuretic34.2%Furosemide100%Part D≥17 patientsAngiotensin receptor blocker (ARB)21.1%Losartan Potassium100%Part D≥18 patients+ 2 more classes in this area
Musculoskeletal
19.7%Xanthine oxidase inhibitor19.7%Allopurinol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2007–2016 per NIH RePORTER. The latest:
- Renal Protective Effects of Circulating Angiopoietin-like-4
University of Alabama at Birmingham
FY2016$319,724R01DK101637 - Renal Protective Effects of Circulating Angiopoietin-like-4
University of Alabama at Birmingham
FY2015$319,725R01DK101637
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- “Idiopathic” minimal change nephrotic syndrome: a podocyte mystery nears the end
American Journal of Physiology-Renal Physiology
2023 - Withdrawal: Isolation and functional analysis of mouse UbA52 gene and its relevance to diabetic nephropathy.
Journal of Biological Chemistry
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”